How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Treatment Planning Software Market
- By Application: Radiation Therapy, Surgical Planning, Dental Treatment Planning, Cardiology Treatment Planning, Orthopedic Treatment Planning
- By Modality: External Beam Radiation Therapy (EBRT), Brachytherapy, Proton Therapy, Stereotactic Radiosurgery (SRS), Stereotactic Body Radiotherapy (SBRT)
- By End User: Hospitals, Cancer Treatment Centers, Dental Clinics, Ambulatory Surgical Centers, Research Institutes
- By Deployment Mode: On-Premise, Cloud-Based, Hybrid
- By Software Type: 3D Treatment Planning Software, 2D Treatment Planning Software, AI-Driven Treatment Planning Software, Image-Guided Treatment Planning Software
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Radiation Therapy leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the Treatment Planning Software Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Application 5
Modality 5
End User 5
Deployment Mode 3
Software Type 4
Companies profiled
Varian Medical Systems (a Siemens Healthineers company)
Elekta AB
RaySearch Laboratories AB
Accuray Incorporated
MIM Software Inc.
Philips Healthcare
Brainlab AG
CIVCO Radiotherapy
Mirada Medical
IBA Dosimetry
ViewRay Inc.
Sun Nuclear Corporation
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Varian Medical Systems (a Siemens Healthineers company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Elekta AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →RaySearch Laboratories AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Accuray Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →MIM Software Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Brainlab AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →CIVCO Radiotherapy
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Mirada Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →IBA Dosimetry
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →ViewRay Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Sun Nuclear Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Medtronic (for specific treatment planning solutions)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Siemens Healthineers
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$12,826M by 2033 · 11.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Radiation Therapy49.2
- Surgical Planning15.8
- Dental Treatment Planning17.2
- Cardiology Treatment Planning8.7
- Orthopedic Treatment Planning9.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,769M → $4,193M · 11.4%
Europe$1,233M → $3,153M · 12.5%
Asia Pacific$1,126M → $2,471M · 10.3%
Latin America$697.0M → $1,863M · 13.1%
Middle East and Africa$536.2M → $1,414M · 12.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.482026
11.482027
11.492028
11.502029
11.512030
11.532031
11.542032
11.552033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Varian Medical Systems (a Siemens Healthineers company)25.3
- Elekta AB24.2
- RaySearch Laboratories AB3.6
- Accuray Incorporated3.8
- MIM Software Inc.3.8
- Philips Healthcare11.4
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Application13.9%
Modality25.1%
End User22.3%
Deployment Mode13.1%
Software Type25.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.0
- Europe24.1
- Asia Pacific18.9
- Latin America14.2
- Middle East and Africa10.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Varian Medical Systems (a Siemens Healthineers company) | 94 | 86 | 75 | 82 | 74 | 94 | 84 |
| Elekta AB | 70 | 88 | 69 | 84 | 82 | 71 | 77 |
| RaySearch Laboratories AB | 65 | 82 | 74 | 83 | 87 | 84 | 79 |
| Accuray Incorporated | 63 | 79 | 60 | 69 | 63 | 60 | 66 |
| MIM Software Inc. | 59 | 73 | 66 | 53 | 65 | 73 | 65 |
| Philips Healthcare | 51 | 69 | 63 | 47 | 61 | 53 | 57 |
| Brainlab AG | 56 | 47 | 56 | 41 | 57 | 64 | 54 |
| CIVCO Radiotherapy | 43 | 58 | 47 | 43 | 52 | 41 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Varian Medical Systems (a Siemens Healthineers company)
- Elekta AB
- RaySearch Laboratories AB
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Varian Medical Systems (a Siemens Healthineers company) | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Elekta AB | ◐ | ✓ | − | ✓ | ✓ | ◐ |
| RaySearch Laboratories AB | ✓ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Accuray Incorporated | − | ✓ | − | ✓ | ◐ | − |
| MIM Software Inc. | ◐ | − | ◐ | − | ◐ | ✓ |
| Philips Healthcare | − | ◐ | − | − | ◐ | ◐ |
| Brainlab AG | ◐ | − | − | − | − | ◐ |
| CIVCO Radiotherapy | − | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Varian Medical Systems (a Siemens Healthineers company)84
2RaySearch Laboratories AB79
3Elekta AB77
4Accuray Incorporated66
5MIM Software Inc.65
6Philips Healthcare57
7Brainlab AG54
8CIVCO Radiotherapy47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Varian Medical Systems (a Siemens Healthineers company)RaySearch Laboratories AB
Challenger1
Strong scale, closing on the leaders.
Elekta AB
Contender3
Focused players with pockets of strength.
Accuray IncorporatedMIM Software Inc.Philips Healthcare
Niche2
Specialists in a single segment or region.
Brainlab AGCIVCO Radiotherapy
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across Treatment Planning Software Market — a $394M beachhead inside a $7.50B market.
Beachhead (SOM)$394Mobtainable near-term
Serviceable (SAM)$2.64Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Radiation Therapy
Best fit — highest urgency & budget in Application.
Economic buyer76 fit
Surgical Planning
Strong fit — clear ROI and a fast path to value.
End user69 fit
Dental Treatment Planning
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Modality & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel28%
Digital / self-serve19%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Treatment Planning Software Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified23%
Evaluation14%
Closed-won8%
$14.3KCAC
$79KLTV
5.5:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Treatment Planning Software Market is a high-growth opportunity — $2.69B by 2033, compounding at 11.0%.
TAM · 2025$1.17Btoday
TAM · 2033$2.69Bforecast
CAGR11.0%2027–2033
Cumulative$16.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.69BTotal addressable market
SAM$1.10BServiceable available market
SOM$216MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.0% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.69BLarge & growingTAM by 2033 at 11.0% CAGR
$1.10BServiceable nowreachable with today’s model
$216MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.10BBear7.1% CAGR
$2.69BBase11.0% CAGR
$3.45BBull14.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Modality optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Treatment Planning Software Market — a $4.94B market by 2033. Plan: grow share from 9.7% to 18.3%.
Market size · 2033$4.94Btotal addressable
Market CAGR3.6%2027–2033
Target share18.3%from 9.7% today
Revenue ambition$904Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.7% | 18.3% | Behind |
| Revenue | $487M | $904M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 37.1% | 42.7% | On track |
| Customer retention | 90.9% | 93.6% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Modality capability
A defensible second engine — invest in Modality to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Modality
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $115M capacity & capability investment
- Greenlight bolt-on M&A in Modality
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Treatment Planning Software Market conversation — a $7.42B market you can size, segment and defend in minutes.
Market size · 2033$7.42Btotal opportunity
Growth8.7%CAGR to 2033
Addressable buyers994+accounts in scope
Typical ROI7.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.4×return on cost, year one
< 3 mopayback period
$84K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Varian Medical Systems (a Siemens Healthineers company)Elekta ABRaySearch Laboratories ABAccuray IncorporatedMIM Software Inc.Philips HealthcareBrainlab AGCIVCO Radiotherapy+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Treatment Planning Software Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Treatment Planning Software Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Treatment of Peritonsillar Abscess Devices Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportTreatment of Parathyroid Disease Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportTreatment of Chemotherapy-Induced Nausea in Cancer Patients Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportTreatment Machines for External Beam Radiotherapy Market
Market size, share, segmentation and regional forecast.
$903M market · 2025 base year
View reportTreatment for Syndromes of Progressive Ataxia and Weakness Disorders Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportTreatment for Mental Health Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportTreatment for Gastroparesis Market
Market size, share, segmentation and regional forecast.
$583M market · 2025 base year
View reportTreatment Electrophysiology (EP) Catheter Market
Market size, share, segmentation and regional forecast.
$713M market · 2025 base year
View reportTreatment Devices for Hemorrhoid Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportTreatment Dental Equipment Market
Market size, share, segmentation and regional forecast.
$418M market · 2025 base year
View reportTreatment Couch Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportTreating Localized Stretch Marks Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.